Myeloproliferative neoplasms are blood cancers that occur when the body makes too many white or red blood cells, or platelets. A few of the MPNs are myelofibrosis (MF), essential thrombocythemia (ET) and polycythemia vera (PV).
Learn from experts more about MPNs, how they are treated and the advances being made through research and clinical trials.
Upcoming EventsSee all events
Friday, June 12, 2020
With the coronavirus pandemic, has research on myeloproliferative neoplasms (MPNs) halted? Are clinical trials still moving forward? Join us for a live Answers Now program on Friday, June 12th at 1 pm PT/4 pm ET as host and MPN patient Andrew Schorr talks to two MPN researchers, Dr.